“We value our partnership with CATALIS Quebec because we work together to achieve our common goal, which is to speed up clinical trials so that those who need them can access treatments more quickly. Thanks to the implementation of the FAST TRACK Evaluation Service, we have been able to optimize the launch times of our clinical trials in many sites in Quebec. This achievement not only positions Quebec as a prime location for clinical research, contributing as such to healthcare innovation in a highly competitive global environment, but it also solidifies GSK’s commitment to improving patient outcomes and advancing medicine.”

Share: